CPC technology class · G21
G21G — Conversion OF Chemical Elements
Conversion of chemical elements; radioactive sources. 629 US utility patents granted 2015–2025, with the leading assignees and year-by-year filing trajectory.
- 629
- US patents granted
- G21
- Parent CPC class
- 20
- Active assignees
- +58%
- 5-yr velocity
CPC subclass G21G — CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES — covers 629 US utility patents granted between 2015 and 2025 according to USPTO PatentsView records. This subclass sits within the broader CPC class G21 (NUCLEAR PHYSICS; NUCLEAR ENGINEERING), one of roughly 250 top-level technology categories in the Cooperative Patent Classification system jointly maintained by the USPTO and the European Patent Office. At the subclass level, four-character codes like G21G give the most practical resolution for tracking a specific technology domain without losing sight of adjacent filings. Every grant here has been classified by a USPTO examiner based on the technical disclosure in the patent specification.
The competitive landscape in G21G is shaped by 20 distinct companies actively filing in this space. Curium US LLC leads with 25 patents, followed by Bracco Diagnostics Inc. at 28 grants and Westinghouse Electric Company LLC at 367. Concentration at the top of the leaderboard indicates whether this technology area is dominated by a handful of incumbents or fragmented across many filers — a useful signal for investors evaluating competitive moats and for product teams mapping freedom-to-operate risk.
Filing trajectory matters as much as static counts. The yearly series on this page plots grants from 2015 through 2025, highlighting whether innovation in G21G is accelerating, plateauing, or cooling. Technology areas with rising post-2020 activity often reflect emerging markets or new platform shifts, while declining filings can signal mature domains where incremental improvement has slowed. Researchers, licensing professionals, and competitive-intelligence teams use these patterns — together with the top-assignee distribution — to decide where to invest, where to license, and where to avoid entanglement. All counts on this page come directly from USPTO PatentsView and reflect US granted utility patents only.
Is G21G innovation accelerating?
US utility-patent grants per year in G21G, 2015–2025 — recent five years are up 58% versus 2015–2019.
Who leads G21G?
The 12 most active assignees in CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES — wider bars mean more grants
- Curium Us 36
Curium US LLC
36 patents
- Bracco Diagnostics 28
Bracco Diagnostics Inc.
28 patents
- Westinghouse Electric
Westinghouse Electric Company LLC
367 patents
- Neuboron Medtech 47
NEUBORON MEDTECH LTD.
47 patents
- Ge-hitachi Nuclear En…
GE-Hitachi Nuclear Energy Americas LLC
215 patents
- Qsa Global 17
QSA GLOBAL INC.
17 patents
- Shine 23
SHINE Technologies, LLC
23 patents
- Bwxt Isotope Technolo… 14
BWXT Isotope Technology Group, Inc.
14 patents
- Framatome 108
FRAMATOME
108 patents
- Jubilant Draximage 20
Jubilant Draximage Inc.
20 patents
- Ge Healthcare 100
GE HEALTHCARE LIMITED
100 patents
- Adelphi Technology 11
Adelphi Technology, Inc.
11 patents
What this shows Curium Us is the most active filer in G21G, holding 25 of the 629 patents in this class. Concentration at the top signals how contestable this technology area is for new entrants.
View data table
| Rank | Company | Patents in G21G |
|---|---|---|
| #1 | Curium US LLC | 36 |
| #2 | Bracco Diagnostics Inc. | 28 |
| #3 | Westinghouse Electric Company LLC | 367 |
| #4 | NEUBORON MEDTECH LTD. | 47 |
| #5 | GE-Hitachi Nuclear Energy Americas LLC | 215 |
| #6 | QSA GLOBAL INC. | 17 |
| #7 | SHINE Technologies, LLC | 23 |
| #8 | BWXT Isotope Technology Group, Inc. | 14 |
| #9 | FRAMATOME | 108 |
| #10 | Jubilant Draximage Inc. | 20 |
| #11 | GE HEALTHCARE LIMITED | 100 |
| #12 | Adelphi Technology, Inc. | 11 |
| #13 | MALLINCKRODT NUCLEAR MEDICINE LLC | 10 |
| #14 | Texas Thorium LLC | 10 |
| #15 | Ion Beam Applications | 72 |
| #16 | ORANO MED | 7 |
| #17 | Neutron Therapeutics LLC | 9 |
| #18 | MALLINCKRODT LLC | 69 |
| #19 | General Atomics | 49 |
| #20 | NIHON MEDI-PHYSICS CO., LTD. | 32 |
About This Class
CPC subclass G21G belongs to class G21.
629 patents were granted in this class between 2015 and 2025.
20 companies actively patent in this space.
Classification System
Cooperative Patent Classification (CPC) is a hierarchical patent classification system used by the USPTO and EPO.
Frequently Asked Questions
What is CPC class G21G?
How many patents have been filed in G21G?
Which company holds the most patents in G21G?
How is patent data for G21G collected?
What is the difference between CPC class and subclass?
Learn More
Explore the patent dataset
Read our methodology — how this data is sourced, computed, and verified.